ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,870.62
      -1.32%
      US Tech 100
      19,880.00
      -2.30%
      Dow Jones
      43,444.99
      -0.70%
      Brent Oil
      71.25
      0.50%
      Bitcoin
      91,398.39
      0.37%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Eliem Therapeutics Inc (ELYM)

      7. Eliem Therapeutics Inc (ELYM) Financials

      Eliem Therapeutics Inc

      Eliem Therapeutics Inc (ELYM)

      NASDAQ
      5.11
      0.00
      (0.00%)
      Closed November 16 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Eliem Therapeutics Inc Financial Summary

      The current ELYM market cap is 342.68M. The company's latest EPS is USD -0.5237 and P/E is -9.76.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -6.71M-5M-5.12M-3.01M-56.37M
      Net Income -5.22M-3.97M-3.64M-1.7M-54.89M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Revenue 000
      Operating Income -35.67M-45.14M-40.28M
      Net Income -52.03M-45.24M-35.12M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Total Assets 116.27M112.74M110.47M109.33M226.02M
      Total Liabilities 3.77M2.99M2.87M2.95M3.74M
      Total Equity 112.5M109.74M107.6M106.38M222.28M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Total Assets 173.24M134.99M110.47M
      Total Liabilities 6.04M6.28M2.87M
      Total Equity 167.2M128.72M107.6M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)
      Operating -23.14M-19.65M-20.6M-1.82M-2.49M
      Investing 4.2M32.23M68.98M13.75M4.11M
      Financing 25k553k841k15k128.42M
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Operating -36.07M-37.37M-20.6M
      Investing -114.97M34.44M68.98M
      Financing 177.23M N/A 841k

      Stats and Ratios

      Market Cap 342.68M
      Price to Earnings Ratio -9.76
      Price to Sales Ratio 0
      Price to Cash Ratio 3.68
      Price to Book Ratio 3.18
      Dividend Yield -

      Share Statistics

      Shares Outstanding 67.06M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change 99.22%
      52 Week High 11.55
      52 Week Low 2.35
      Spread (Intraday) 0.4 (7.55%)

      Company Info

      Company Name Eliem Therapeutics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://climbbio.com
      Industry pharmaceutical preparations (2834)